An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
|Articles|February 10, 2022
Popular GBM Patient Questions Answered by Dr. Susan Chang at UCSF
The End Brain Cancer Initiative was able to sit down with the renowned doctor, Dr. Susan Chang.
Advertisement
The End Brain Cancer Initiative was able to sit down with the renowned doctor, Dr. Susan Chang, Neuro-oncologist, Director of the UCSF Neuro-Oncology Department and Co-Director of the Sheri Sobrato Brisson Brain Cancer Survivorship Program.
We were able to ask her some of the most commonly asked questions by our patients and caregivers. We were so thankful to spend this valuable time with Dr. Chang and appreciate her thoughts and passion for the Brain Tumor/Cancer Community. Dr. Chang was able answer patient solicited questions about things like the Keto Diet to a possible genetic component to Glioblastoma. It’s about 8 minutes long and well worth the time spent!
Link can be found here:
For additional disease education and patient engagement opportunities, please also follow End Brain Cancer on
Advertisement
Related to this article
After 19 years of survivorship, one cancer survivor reflects on life's changing seasons, managing scan anxiety and finding support beyond treatment.
Psychiatrist Dr. Yesne Alici of Memorial Sloan Kettering Cancer Center answers questions about family relationships during cancer, from asking for help to talking with children and friends.
Among more than 12,000 cancer survivors 65 and older, those who stayed physically active after diagnosis tended to have lower health care costs, an American Cancer Society study published Oct. 21, 2026, in CANCER found.
The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least 13 mutations per megabase.
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Traditional Approval to Keytruda for TMB-H Solid Tumors
2
Psychiatrist Answers Questions About Family and Relationships During Cancer
3
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
4
Finding My Rhythm Again: What Fall Means to Me After Cancer
5